Jiang Zhong Pharmaceutical Co.,Ltd (SHA:600750)

Market Cap	13.86B
Revenue (ttm)	4.35B
Net Income (ttm)	804.09M
Shares Out	628.85M
EPS (ttm)	1.27
PE Ratio	17.33
Forward PE	16.38
Dividend	1.20 (5.46%)
Ex-Dividend Date	Jun 20, 2025

Volume	3,602,769
Average Volume	3,976,527
Open	21.97
Previous Close	21.96
Day's Range	21.87 - 22.05
52-Week Range	18.17 - 25.95
Beta	0.15
RSI	42.93
Earnings Date	Aug 22, 2025

About SHA:600750

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China. The company offers OTC products for spleen and stomach, intestinal tract, anorectal, throat cough and asthma, supplements and minerals, and chronic diseases. It also offers health products for high-end nourishment, rehabilitation nutrition, gastrointestinal health, liver and gallbladder health, dietary nutrition, basic vitamins, personal care essential oils, and other businesses; and pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 4,182
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600750

Financial Performance

In 2024, SHA:600750's revenue was 4.44 billion, a decrease of -2.59% compared to the previous year's 4.55 billion. Earnings were 788.19 million, an increase of 9.67%.